Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A25351 | 21936721 | Scand J Gastroenterol | Short-term inhibition of SREBP-1c expression reverses diet-induced non-alcoholic fatty liver disease in mice. | 2011 | Details |
| A25352 | 21935484 | PLoS One | The in utero programming effect of increased maternal androgens and a direct fetal intervention on liver and metabolic function in adult sheep. | 2011 | Details |
| A25353 | 21933666 | Clin Biochem | Clinical significance of conventional serum autoantibodies for various liver diseases in a Chinese population. | 2011 | Details |
| A25355 | 21932408 | Hepatology | Low doses of bisphenol A induce gene expression related to lipid synthesis and trigger triglyceride accumulation in adult mouse liver. | 2011 | Details |
| A25356 | 21932374 | Liver Transpl | Excellent posttransplant survival for patients with nonalcoholic steatohepatitis in the United States. | 2012 | Details |
| A25357 | 21931690 | PLoS One | Upregulation of hemoglobin expression by oxidative stress in hepatocytes and its implication in nonalcoholic steatohepatitis. | 2011 | Details |
| A25358 | 21930939 | Proc Natl Acad Sci U S A | Cellular mechanism of insulin resistance in nonalcoholic fatty liver disease. | 2011 | Details |
| A25359 | 21930273 | Atherosclerosis | NASH and atherosclerosis are two aspects of a shared disease: central role for macrophages. | 2011 | Details |
| A25360 | 21929649 | J Gastroenterol Hepatol | Peroxisome proliferator-activated receptor-α agonist, Wy 14,643, improves metabolic indices, steatosis and ballooning in diabetic mice with non-alcoholic steatohepatitis. | 2012 | Details |
| A25361 | 21926952 | Minerva Ginecol | [Polycystic ovarian syndrome incidence in young women with non-alcoholic fatty liver disease]. | 2011 | Details |
| A25362 | 21920102 | S Afr Med J | APRI: a simple bedside marker for advanced fibrosis that can avoid liver biopsy in patients with NAFLD/NASH. | 2011 | Details |
| A25363 | 21918648 | Curr Gerontol Geriatr Res | Mechanisms and implications of age-related changes in the liver: nonalcoholic Fatty liver disease in the elderly. | 2011 | Details |
| A25364 | 21917086 | Hepatol Res | Hepatocellular carcinoma in non-alcoholic steatohepatitis: Growing evidence of an epidemic? | 2011 | Details |
| A25365 | 21905818 | Int J Pediatr Obes | Fatty liver disease in obese children--relation to other metabolic risk factors. | 2011 | Details |
| A25366 | 21915061 | Eur J Gastroenterol Hepatol | Nonalcoholic fatty liver disease is associated with blood pressure in hypertensive and nonhypertensive individuals from the general population with normal levels of alanine aminotransferase. | 2011 | Details |
| A25367 | 21913918 | Eur J Clin Invest | Characterization of nonalcoholic fatty liver disease unrelated to the metabolic syndrome. | 2011 | Details |
| A25368 | 21912741 | J Nutr Metab | Putative factors that may modulate the effect of exercise on liver fat: insights from animal studies. | 2011 | Details |
| A25369 | 21912450 | World J Gastroenterol | Pediatric nonalcoholic fatty liver disease, metabolic syndrome and cardiovascular risk. | 2011 | Details |
| A25370 | 21912108 | Ann Nutr Metab | Early-onset metabolic syndrome in prepubertal obese children and the possible role of alanine aminotransferase as marker of metabolic syndrome. | 2011 | Details |
| A25372 | 21911891 | Ann Hepatol | Plasminogen activator inhibitor type 1 serum levels and 4G/5G gene polymorphism in morbidly obese Hispanic patients with non-alcoholic fatty liver disease. | 2011 | Details |
| A25373 | 21911890 | Ann Hepatol | Decrease of aminotransferase levels in obese women is related to body weight reduction, irrespective of type of diet. | 2011 | Details |
| A25374 | 21910085 | Adv Exp Med Biol | Glycosphingolipids and insulin resistance. | 2011 | Details |
| A25375 | 21910084 | Adv Exp Med Biol | Sphingolipids and hepatic steatosis. | 2011 | Details |
| A25376 | 21910083 | Adv Exp Med Biol | Adipose tissue and ceramide biosynthesis in the pathogenesis of obesity. | 2011 | Details |
| A25377 | 21908065 | Diabetes Res Clin Pract | Which metabolic syndrome criteria best predict the presence of non-alcoholic fatty liver disease? | 2011 | Details |
| A25378 | 21907687 | J Hepatol | Endogenous formation of Nε-(carboxymethyl)lysine is increased in fatty livers and induces inflammatory markers in an in vitro model of hepatic steatosis. | 2011 | Details |
| A25379 | 21907177 | Am J Pathol | Protease-activated receptor 1 and hematopoietic cell tissue factor are required for hepatic steatosis in mice fed a Western diet. | 2011 | Details |
| A25380 | 21906580 | Am J Pathol | Melanocortin 4 receptor-deficient mice as a novel mouse model of nonalcoholic steatohepatitis. | 2011 | Details |
| A25381 | 21906525 | Zhong Xi Yi Jie He Xue Bao | [Effects of Chinese herbal medicine Jiangzhi Granule on expressions of liver X receptor α and sterol regulatory element-binding protein-1c in a rat model of non-alcoholic fatty liver disease]. | 2011 | Details |
| A25382 | 21906297 | BMC Res Notes | Markedly lower follow-up rate after liver biopsy in patients with non-alcoholic fatty liver diseases than those with viral hepatitis in Japan. | 2011 | Details |
| A25383 | 21904208 | Eur J Gastroenterol Hepatol | Steatosis degree, measured by morphometry, is linked to other liver lesions and metabolic syndrome components in patients with NAFLD. | 2011 | Details |
| A25384 | 21903748 | J Pharmacol Exp Ther | Serotonin receptor type 3 antagonists improve obesity-associated fatty liver disease in mice. | 2011 | Details |
| A25385 | 21901256 | Dig Dis Sci | Bifidobacterium longum with fructo-oligosaccharides in patients with non alcoholic steatohepatitis. | 2011 | Details |
| A25386 | 21901160 | PLoS One | Maternal obesity during gestation impairs fatty acid oxidation and mitochondrial SIRT3 expression in rat offspring at weaning. | 2011 | Details |
| A25387 | 21898634 | Ultrasound Obstet Gynecol | Ultrasonographic and laboratory markers of metabolic and cardiovascular disease risk in obese women with polycystic ovary syndrome. | 2012 | Details |
| A25390 | 21898479 | Hepatology | Feasibility and diagnostic performance of the FibroScan XL probe for liver stiffness measurement in overweight and obese patients. | 2011 | Details |
| A25391 | 21894552 | J Mol Med (Berl) | Genetic variants in candidate genes influencing NAFLD progression. | 2011 | Details |
| A25392 | 21894514 | Endocrine | Non-alcoholic fatty liver disease and cardiovascular risk: metabolic aspects and novel treatments. | 2011 | Details |
| A25393 | 21894292 | Med Ultrason | Association between fatty liver disease and carotid atherosclerosis in patients with uncomplicated type 2 diabetes mellitus. | 2011 | Details |
| A25394 | 21894290 | Med Ultrason | Effect of severity of steatosis as assessed ultrasonographically on hepatic vascular indices in non-alcoholic fatty liver disease. | 2011 | Details |
| A25395 | 21894008 | Dig Dis | Obesity and fatty liver are 'grease' for the machinery of hepatic fibrosis. | 2011 | Details |
| A25396 | 21893698 | J Physiol Pharmacol | The common adiponutrin variant p.I148M does not confer gallstone risk but affects fasting glucose and triglyceride levels. | 2011 | Details |
| A25397 | 21893273 | Gastroenterol Clin North Am | Nonalcoholic fatty liver disease: pharmacologic and surgical options. | 2011 | Details |
| A25398 | 21892559 | Nutr Hosp | Molecular mechanisms of steatosis in nonalcoholic fatty liver disease. | 2012 | Details |
| A25400 | 21890080 | Am J Cardiol | Comparison of the frequency of coronary artery disease in alcohol-related versus non-alcohol-related endstage liver disease. | 2011 | Details |
| A25401 | 21888902 | Clin Chim Acta | Serum pigment epithelium-derived factor levels are increased in patients with biopsy-proven nonalcoholic fatty liver disease and independently associated with liver steatosis. | 2011 | Details |
| A25403 | 21886908 | Sci Pharm | Type 2 Diabetes Mellitus-Induced Hyperglycemia in Patients with NAFLD and Normal LFTs: Relationship to Lipid Profile, Oxidative Stress and Pro-Inflammatory Cytokines. | 2011 | Details |
| A25404 | 21886843 | PLoS One | Circulating microRNAs in patients with chronic hepatitis C and non-alcoholic fatty liver disease. | 2011 | Details |
| A25405 | 21885686 | Am J Physiol Gastrointest Liver Physiol | Estrogen deficiency worsens steatohepatitis in mice fed high-fat and high-cholesterol diet. | 2011 | Details |
| A25406 | 21885479 | Exp Biol Med (Maywood) | The emerging roles of fatty acid translocase/CD36 and the aryl hydrocarbon receptor in fatty liver disease. | 2011 | Details |
| A25407 | 21884248 | J Gastroenterol Hepatol | Outcomes after curative treatment for cryptogenic cirrhosis-associated hepatocellular carcinoma satisfying the Milan criteria. | 2011 | Details |
| A25408 | 21883454 | J Gastroenterol Hepatol | Transitional features of histologic type of non-alcoholic fatty liver disease in Korean young men. | 2012 | Details |
| A25409 | 21883436 | Diabet Med | Increased prevalence of chronic kidney disease in patients with Type 1 diabetes and non-alcoholic fatty liver. | 2012 | Details |
| A25410 | 21881966 | Metab Brain Dis | Non-alcoholic fatty liver induces insulin resistance and metabolic disorders with development of brain damage and dysfunction. | 2011 | Details |
| A25411 | 21880110 | BJOG | A novel cause for abnormal liver function tests in pregnancy and the puerperium: non-alcoholic fatty liver disease. | 2011 | Details |
| A25412 | 21878620 | J Biol Chem | Expression and characterization of a PNPLA3 protein isoform (I148M) associated with nonalcoholic fatty liver disease. | 2011 | Details |
| A25413 | 21878559 | Drug Metab Dispos | Variations in ATP-binding cassette transporter regulation during the progression of human nonalcoholic fatty liver disease. | 2011 | Details |
| A25414 | 21878129 | BMC Res Notes | Clinical correlation of nonalcoholic fatty liver disease in a Chinese taxi drivers population in Taiwan: Experience at a teaching hospital. | 2011 | Details |
| A25415 | 25755327 | J Clin Exp Hepatol | Nuclear Factor High-mobility Group Box1 Mediating the Activation of Toll-like Receptor 4 Signaling in Hepatocytes in the Early Stage of Non-alcoholic Fatty Liver Disease in Mice. | 2011 | Details |
| A25416 | 25755326 | J Clin Exp Hepatol | Safety of Complete and Sustained Prophylaxis Withdrawal in Patients Liver-transplanted for Hepatitis B Virus-related Cirrhosis at Low Risk of Hepatitis B Virus Recurrence. | 2011 | Details |
| A25417 | 21876630 | World J Gastroenterol | Nutrition and physical activity in NAFLD: an overview of the epidemiological evidence. | 2011 | Details |
| A25418 | 21876629 | World J Gastroenterol | Nutritional recommendations for patients with non-alcoholic fatty liver diseases. | 2011 | Details |
| A25420 | 21875310 | Crit Rev Clin Lab Sci | Non-alcoholic fatty liver disease. | 2011 | Details |
| A25421 | 21875072 | J Agric Food Chem | Synthesis of carboxymethylated and quaternized chitosans and their therapeutic effect on nonalcoholic Fatty liver disease. | 2011 | Details |
| A25422 | 21873555 | FASEB J | Kupffer cell depletion prevents but has no therapeutic effect on metabolic and inflammatory changes induced by a high-fat diet. | 2011 | Details |
| A25423 | 21872093 | Prim Care | Care of chronic liver disease. | 2011 | Details |
| A25425 | 21865319 | Drug Metab Dispos | Differences in the disposition of silymarin between patients with nonalcoholic fatty liver disease and chronic hepatitis C. | 2011 | Details |
| A25426 | 21862168 | Diabetes Res Clin Pract | Serum sex hormone-binding globulin levels are independently associated with nonalcoholic fatty liver disease in people with type 2 diabetes. | 2011 | Details |
| A25428 | 21859358 | Scand J Clin Lab Invest | Serum osteocalcin levels in patients with nonalcoholic fatty liver disease: association with ballooning degeneration. | 2011 | Details |
| A25429 | 21857953 | PLoS One | Increased diacylglycerols characterize hepatic lipid changes in progression of human nonalcoholic fatty liver disease; comparison to a murine model. | 2011 | Details |
| A25430 | 21855538 | Exp Mol Pathol | Elevated systemic monocyte chemoattractrant protein-1 in hepatic steatosis without significant hepatic inflammation. | 2011 | Details |
| A25431 | 21853259 | Environ Health Prev Med | Development of novel rat model for high-fat and high-cholesterol diet-induced steatohepatitis and severe fibrosis progression in SHRSP5/Dmcr. | 2011 | Details |
| A25432 | 21853118 | PLoS One | Hepatic n-3 polyunsaturated fatty acid depletion promotes steatosis and insulin resistance in mice: genomic analysis of cellular targets. | 2011 | Details |
| A25433 | 21852905 | Korean J Radiol | Evaluation of portal venous velocity with Doppler ultrasound in patients with nonalcoholic fatty liver disease. | 2011 | Details |
| A25434 | 21850244 | PLoS One | Association between markers of fatty liver disease and impaired glucose regulation in men and women from the general population: the KORA-F4-study. | 2011 | Details |
| A25435 | 21846782 | Gut | Prevalence of non-alcoholic fatty liver disease and advanced fibrosis in Hong Kong Chinese: a population study using proton-magnetic resonance spectroscopy and transient elastography. | 2011 | Details |
| A25436 | 21845221 | J Nutr Metab | NAFLD, Estrogens, and Physical Exercise: The Animal Model. | 2011 | Details |
| A25437 | 21843565 | Arch Med Res | Treatment of atherogenic liver based on the pathogenesis of nonalcoholic fatty liver disease: a novel approach to reduce cardiovascular risk? | 2011 | Details |
| A25438 | 21841322 | Intern Med | Serum dehydroepiandrosterone sulphate levels in patients with non-alcoholic fatty liver disease. | 2011 | Details |
| A25439 | 21840395 | Biochim Biophys Acta | Genetic modifiers of non-alcoholic fatty liver disease progression. | 2011 | Details |
| A25440 | 21839075 | Eur J Pharmacol | Berberine reducing insulin resistance by up-regulating IRS-2 mRNA expression in nonalcoholic fatty liver disease (NAFLD) rat liver. | 2011 | Details |
| A25441 | 21837751 | Hepatology | Methionine adenosyltransferase 1A gene deletion disrupts hepatic very low-density lipoprotein assembly in mice. | 2011 | Details |
| A25442 | 21836480 | Am J Surg Pathol | Centrizonal arteries and microvessels in nonalcoholic steatohepatitis. | 2011 | Details |
| A25443 | 21836057 | Am J Physiol Gastrointest Liver Physiol | Fast food diet mouse: novel small animal model of NASH with ballooning, progressive fibrosis, and high physiological fidelity to the human condition. | 2011 | Details |
| A25444 | 21835806 | J Gerontol A Biol Sci Med Sci | Aging is associated with a shift of fatty metabolism toward lipogenesis. | 2011 | Details |
| A25445 | 21834002 | NMR Biomed | In vivo characterization of the liver fat ¹H MR spectrum. | 2010 | Details |
| A25446 | 21830099 | Eur Radiol | Signal profile on Gd-EOB-DTPA-enhanced MR imaging in non-alcoholic steatohepatitis and liver cirrhosis induced in rats: correlation with transporter expression. | 2011 | Details |
| A25447 | 21824690 | Eur J Med Chem | Comparative study on antioxidant capacity of flavonoids and their inhibitory effects on oleic acid-induced hepatic steatosis in vitro. | 2011 | Details |
| A25448 | 21821952 | Biosci Biotechnol Biochem | Isolation and anti-fatty liver activity of a novel cerebroside from the sea cucumber Acaudina molpadioides. | 2011 | Details |
| A25449 | 21821020 | Exp Mol Pathol | Liver mitochondrial function and redox status in an experimental model of non-alcoholic fatty liver disease induced by monosodium L-glutamate in rats. | 2011 | Details |
| A25450 | 21818154 | Obesity (Silver Spring) | Perinephric and epididymal fat affect hepatic metabolism in rats. | 2011 | Details |
| A25452 | 21817841 | Nihon Shokakibyo Gakkai Zasshi | The efficacy of ezetimibe on nonalcoholic fatty liver disease (NAFLD). | 2011 | Details |
| A25453 | 21817060 | Am J Physiol Gastrointest Liver Physiol | Altered lipid metabolism in Hfe-knockout mice promotes severe NAFLD and early fibrosis. | 2011 | Details |
| A25454 | 21816784 | J Clin Endocrinol Metab | Nonalcoholic fatty liver disease is associated with low circulating levels of insulin-like growth factor-I. | 2011 | Details |
| A25455 | 21814826 | J Mol Med (Berl) | Increased hepatic apoptosis in high-fat diet-induced NASH in rats may be associated with downregulation of hepatic stimulator substance. | 2011 | Details |
| A25456 | 21813474 | Gut | Pharmacological inhibition of the chemokine CCL2 (MCP-1) diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury. | 2011 | Details |
| A25457 | 21810560 | Eur J Med Res | The non-invasive (13)C-methionine breath test detects hepatic mitochondrial dysfunction as a marker of disease activity in non-alcoholic steatohepatitis. | 2011 | Details |
| A25458 | 21810223 | Ital J Pediatr | The use of ultrasound in clinical setting for children affected by NAFLD: is it safe and accurate? | 2011 | Details |
| A25459 | 21809356 | Hepatology | Nuclear factor high-mobility group box1 mediating the activation of Toll-like receptor 4 signaling in hepatocytes in the early stage of nonalcoholic fatty liver disease in mice. | 2011 | Details |
| A25460 | 21808028 | Proc Natl Acad Sci U S A | Reversal of muscle insulin resistance with exercise reduces postprandial hepatic de novo lipogenesis in insulin resistant individuals. | 2011 | Details |